451 related articles for article (PubMed ID: 29533182)
21. Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis.
Ou S; Chen H; Wang H; Ye J; Liu H; Tao Y; Ran S; Mu X; Liu F; Zhu S; Luo K; Guan Z; Jin Y; Huang R; Song Y; Liu SL
J Transl Med; 2023 Oct; 21(1):704. PubMed ID: 37814323
[TBL] [Abstract][Full Text] [Related]
22. Bacterial Subspecies Linked With Aggressive Colorectal Cancer Tumors.
Harris E
JAMA; 2024 May; 331(18):1526. PubMed ID: 38639945
[No Abstract] [Full Text] [Related]
23. Fusobacterium nucleatum tumor DNA levels are associated with survival in colorectal cancer patients.
Kunzmann AT; Proença MA; Jordao HW; Jiraskova K; Schneiderova M; Levy M; Liska V; Buchler T; Vodickova L; Vymetalkova V; Silva AE; Vodicka P; Hughes DJ
Eur J Clin Microbiol Infect Dis; 2019 Oct; 38(10):1891-1899. PubMed ID: 31367996
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA EVADR induced by Fusobacterium nucleatum infection promotes colorectal cancer metastasis.
Lu X; Xu Q; Tong Y; Zhang Z; Dun G; Feng Y; Tang J; Han D; Mao Y; Deng L; He X; Li Q; Xiang Y; Wang F; Zeng D; Tang B; Mao X
Cell Rep; 2022 Jul; 40(3):111127. PubMed ID: 35858553
[TBL] [Abstract][Full Text] [Related]
25. Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.
Hashemi Goradel N; Heidarzadeh S; Jahangiri S; Farhood B; Mortezaee K; Khanlarkhani N; Negahdari B
J Cell Physiol; 2019 Mar; 234(3):2337-2344. PubMed ID: 30191984
[TBL] [Abstract][Full Text] [Related]
26. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma.
Castellarin M; Warren RL; Freeman JD; Dreolini L; Krzywinski M; Strauss J; Barnes R; Watson P; Allen-Vercoe E; Moore RA; Holt RA
Genome Res; 2012 Feb; 22(2):299-306. PubMed ID: 22009989
[TBL] [Abstract][Full Text] [Related]
27. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
[TBL] [Abstract][Full Text] [Related]
28. Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner.
Udayasuryan B; Zhou Z; Ahmad RN; Sobol P; Deng C; Nguyen TTD; Kodikalla S; Morrison R; Goswami I; Slade DJ; Verbridge SS; Lu C
Commun Biol; 2024 May; 7(1):551. PubMed ID: 38720110
[TBL] [Abstract][Full Text] [Related]
29.
Xu C; Fan L; Lin Y; Shen W; Qi Y; Zhang Y; Chen Z; Wang L; Long Y; Hou T; Si J; Chen S
Gut Microbes; 2021; 13(1):1980347. PubMed ID: 34632963
[TBL] [Abstract][Full Text] [Related]
30. Fusobacterium nucleatum and Bacteroides fragilis detection in colorectal tumours: Optimal target site and correlation with total bacterial load.
Rye MS; Garrett KL; Holt RA; Platell CF; McCoy MJ
PLoS One; 2022; 17(1):e0262416. PubMed ID: 34995318
[TBL] [Abstract][Full Text] [Related]
31. Effects of metronidazole on colorectal cancer occurrence and colorectal cancer liver metastases by regulating Fusobacterium nucleatum in mice.
Wang M; Li Y; Yang X; Liu Z; Wang K; Gong D; Li J
Immun Inflamm Dis; 2023 Nov; 11(11):e1067. PubMed ID: 38018574
[TBL] [Abstract][Full Text] [Related]
32. Association of Fusobacterium nucleatum infection and colorectal cancer: A Mexican study.
Cuellar-Gómez H; Ocharán-Hernández ME; Calzada-Mendoza CC; Comoto-Santacruz DA
Rev Gastroenterol Mex (Engl Ed); 2022; 87(3):277-284. PubMed ID: 34312118
[TBL] [Abstract][Full Text] [Related]
33. Knock down of BMSC-derived Wnt3a or its antagonist analogs attenuate colorectal carcinogenesis induced by chronic Fusobacterium nucleatum infection.
Lin R; Han C; Ding Z; Shi H; He R; Liu J; Qian W; Zhang Q; Fu X; Deng X; Zhou S; Hou X
Cancer Lett; 2020 Dec; 495():165-179. PubMed ID: 32920199
[TBL] [Abstract][Full Text] [Related]
34. The who, where and how of fusobacteria and colon cancer.
Sears CL
Elife; 2018 Mar; 7():. PubMed ID: 29533185
[TBL] [Abstract][Full Text] [Related]
35. Diets That Promote Colon Inflammation Associate With Risk of Colorectal Carcinomas That Contain Fusobacterium nucleatum.
Liu L; Tabung FK; Zhang X; Nowak JA; Qian ZR; Hamada T; Nevo D; Bullman S; Mima K; Kosumi K; da Silva A; Song M; Cao Y; Twombly TS; Shi Y; Liu H; Gu M; Koh H; Li W; Du C; Chen Y; Li C; Li W; Mehta RS; Wu K; Wang M; Kostic AD; Giannakis M; Garrett WS; Hutthenhower C; Chan AT; Fuchs CS; Nishihara R; Ogino S; Giovannucci EL
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1622-1631.e3. PubMed ID: 29702299
[TBL] [Abstract][Full Text] [Related]
36. FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk2.
Guo P; Tian Z; Kong X; Yang L; Shan X; Dong B; Ding X; Jing X; Jiang C; Jiang N; Yu Y
J Exp Clin Cancer Res; 2020 Sep; 39(1):202. PubMed ID: 32993749
[TBL] [Abstract][Full Text] [Related]
37.
Hong J; Guo F; Lu SY; Shen C; Ma D; Zhang X; Xie Y; Yan T; Yu T; Sun T; Qian Y; Zhong M; Chen J; Peng Y; Wang C; Zhou X; Liu J; Liu Q; Ma X; Chen YX; Chen H; Fang JY
Gut; 2021 Nov; 70(11):2123-2137. PubMed ID: 33318144
[TBL] [Abstract][Full Text] [Related]
38. ANGPTL4-Mediated Promotion of Glycolysis Facilitates the Colonization of
Zheng X; Liu R; Zhou C; Yu H; Luo W; Zhu J; Liu J; Zhang Z; Xie N; Peng X; Xu X; Cheng L; Yuan Q; Huang C; Zhou X
Cancer Res; 2021 Dec; 81(24):6157-6170. PubMed ID: 34645607
[TBL] [Abstract][Full Text] [Related]
39. TOX expression decreases with progression of colorectal cancers and is associated with CD4 T-cell density and Fusobacterium nucleatum infection.
Chen T; Li Q; Zhang X; Long R; Wu Y; Wu J; Fu X
Hum Pathol; 2018 Sep; 79():93-101. PubMed ID: 29792893
[TBL] [Abstract][Full Text] [Related]
40.
Chen Y; Chen Y; Zhang J; Cao P; Su W; Deng Y; Zhan N; Fu X; Huang Y; Dong W
Theranostics; 2020; 10(1):323-339. PubMed ID: 31903123
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]